PRESCRIBING · PART D · 2024
Total Rx claims
169
Beneficiaries
—
Total drug cost
$233K
Distinct drugs
9
Brand share
69.2%
Top prescribed drugs
Imipenem/Cilastatin Sodium48 claims
Atorvastatin Calcium27 claims
Bictegrav/Emtricit/Tenofov Ala19 claims
Abacavir/Dolutegravir/Lamivudi16 claims
Lisinopril14 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
CROSS-REFERENCE